The University of Texas MD Anderson Cancer Center
Asha S. Multani
https://www.mdanderson.org/research/research-resources/core-facilities/cytogenetics-and-cell-authentication-core.html
RRID: RRID:SCR_026262
1.) Houl JH, Bagheri-Yarmand R, Kunnimalaiyaan M, Mendez PM, Kidd JL, Dadbin A, Ruiz-Jurado A, Parekh PA, Henderson YC, Chari NS, Thennavan A, Powell RT, Stephan CC, Zhao X, Maniakas A, Nurieva R, Busaidy NL, Cabanillas ME, Dadu R, Zafereo M, Wang JR, Lai SY, Hofmann MC (2026 Jan 16). Role of the ETV5/p38 signaling axis in aggressive thyroid cancer cells Molecular cancer therapeutics, (), OF1-OF16. . PMCID: 12818543.
2.) Rinkenbaugh AL, Qi Y, Cai S, Shao J, Baameur Hancock F, Jeter-Jones SL, Zhang X, Powell E, Huo L, Lau R, Fu C, Gould R, den Hollander P, Ravenberg EE, White JB, Rauch GM, Arun B, Yam C, Thompson AM, Echeverria GV, Moulder SL, Symmans WF, Chang JT, Piwnica-Worms H (2025 Nov 3). An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy. Cancer research, 85(21), 4062-4080. . PMCID: 12456255.
3.) Stitzlein LM, Nam D, Hernandez FA, Patel KH, Poche A, Ma H, Impelman K, Gumin J, Wang H, Wang J, Gadd S, Zaky W, Becher O, Dudley RW, Lang FF, Sareddy GR, Chandra J (2025 Jan-Dec). Combined inhibition of lysine-specific demethylase 1 and kinase signaling as a preclinical treatment strategy in glioblastoma. Neuro-oncology advances, 7(1), vdaf246. . PMCID: 12768500.
Facility offers conventional as well as molecular cytogenetic services including karyotyping, analysis of genomic instability, fluorescence in situ hybridization, telomere analysis, Spectral Karyotyping, species identification, inter-species and intra-species cell line contamination, STR fingerprinting service for cell line authentication, mycoplasma contamination testing and distribution of cell lines.
